At the European Society for Medical Oncology (ESMO) 2025 event, held in Berlin, Germany, between 17-21 October, Celcuity ...

An extract from a desert berry used in traditional Chinese medicine restored insulin function and stabilized metabolism in ...

These particles don't just sit harmlessly in the body; they trigger chronic inflammation, oxidative stress, and DNA damage.

MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

Hutchmed unveiled new details on its expanding oncology pipeline and research strategy, including the launch of its ...

Q3 2025 Earnings Call Transcript November 6, 2025 Pharming Group N.V. beats earnings expectations. Reported EPS is $0.1, expectations were $0.05. Operator: Good day, and thank you for standing by.

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T ...

Prediabetes burden is rising globally and in India. The latest IDF 2025 Atlas estimated that in 2024, 634.8 million adults (12%) worldwide had IGT, including 89.9 million in India, projected ...